{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:19:29Z","timestamp":1786123169909,"version":"build-2736575974"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1213\/ane.0b013e3181da91bb","type":"journal-article","created":{"date-parts":[[2010,5,4]],"date-time":"2010-05-04T02:41:44Z","timestamp":1272940904000},"page":"1597-1606","source":"Crossref","is-referenced-by-count":38,"title":["Propofol Reduces the Distribution and Clearance of Midazolam"],"prefix":"10.1213","volume":"110","author":[{"given":"Bart Jan","family":"Lichtenbelt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Olofsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack W.","family":"van Kleef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel M.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Vuyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210902","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1213\/ane.0b013e31819e4058","article-title":"Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.","volume":"108","author":"Vuyk","year":"2009","journal-title":"Anesth Analg"},{"key":"R2-15-20210902","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1213\/00000539-199709000-00013","article-title":"The effects of midazolam on propofol-induced anesthesia: propofol dose requirements, mood profiles, and perioperative dreams.","volume":"85","author":"Oxorn","year":"1997","journal-title":"Anesth Analg"},{"key":"R3-15-20210902","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/bja\/67.5.539","article-title":"Propofol and midazolam act synergistically in combination.","volume":"67","author":"Short","year":"1991","journal-title":"Br J Anaesth"},{"key":"R4-15-20210902","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/bja\/69.2.162","article-title":"Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil.","volume":"69","author":"Short","year":"1992","journal-title":"Br J Anaesth"},{"key":"R5-15-20210902","first-page":"75","article-title":"Total intravenous anesthesia with propofol vs. propofolmidazolam in oncology patients.","volume":"26","author":"Gonzalez-Arrieta","year":"1995","journal-title":"Arch Med Res"},{"key":"R6-15-20210902","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003088-200443090-00002","article-title":"Strategies to optimise propofol-opioid anaesthesia.","volume":"43","author":"Lichtenbelt","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R8-15-20210902","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/cp.1999.v66.100038001","article-title":"Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.","volume":"66","author":"Hamaoka","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"R9-15-20210902","first-page":"143","article-title":"Aging increases pharmacodynamic sensitivity to the hypnotic effects of midazolam.","volume":"80","author":"Jacobs","year":"1995","journal-title":"Anesth Analg"},{"key":"R10-15-20210902","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00003246-199805000-00015","article-title":"Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting.","volume":"26","author":"Carrasco","year":"1998","journal-title":"Crit Care Med"},{"key":"R11-15-20210902","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/bja\/69.3.240","article-title":"Synergistic interaction between midazolam and propofol.","volume":"69","author":"McClune","year":"1992","journal-title":"Br J Anaesth"},{"key":"R12-15-20210902","doi-asserted-by":"crossref","first-page":"S1408","DOI":"10.1016\/S0003-4975(02)04059-6","article-title":"PulseCO: a less-invasive method to monitor cardiac output from arterial pressure after cardiac surgery.","volume":"74","author":"Hamilton","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"R13-15-20210902","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0378-4347(00)82319-1","article-title":"High-performance liquid chromatographic assay to determine midazolam and flumazenil simultaneously in human plasma.","volume":"530","author":"Vletter","year":"1990","journal-title":"J Chromatogr"},{"key":"R14-15-20210902","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1097\/00000542-199912000-00032","article-title":"First-pass lung uptake and pulmonary clearance of propofol: assessment with a recirculatory indocyanine green pharmacokinetic model.","volume":"91","author":"Kuipers","year":"1999","journal-title":"Anesthesiology"},{"key":"R17-15-20210902","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1552-4604.1997.tb04326.x","article-title":"Stability and performance of a population pharmacokinetic model.","volume":"37","author":"Ette","year":"1997","journal-title":"J Clin Pharmacol"},{"key":"R18-15-20210902","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/00000542-199812000-00020","article-title":"Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting.","volume":"89","author":"Zomorodi","year":"1998","journal-title":"Anesthesiology"},{"key":"R19-15-20210902","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/clpt.1990.192","article-title":"Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam.","volume":"48","author":"Buhrer","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"R20-15-20210902","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00558225","article-title":"Pharmacokinetics of midazolam in patients recovering from cardiac surgery.","volume":"37","author":"Maitre","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"R21-15-20210902","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00000542-198461010-00006","article-title":"Effect of age, gender, and obesity on midazolam kinetics.","volume":"61","author":"Greenblatt","year":"1984","journal-title":"Anesthesiology"},{"key":"R22-15-20210902","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.clpt.6100237","article-title":"Influence of CYP3A5 genotype on the pharmacokinetics and pharmacodynamics of the cytochrome P4503A probes alfentanil and midazolam.","volume":"82","author":"Kharasch","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"R23-15-20210902","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1067\/mcp.2003.23","article-title":"An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity.","volume":"73","author":"Rogers","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"R24-15-20210902","first-page":"86","article-title":"Flumazenil pretreatment minimizes midazolam-induced central nervous system CNS effects during hepatic CYP3A phenotyping in healthy subjects.","volume":"71","author":"Rogers","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R25-15-20210902","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2044.2005.04110.x","article-title":"Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro.","volume":"60","author":"Mc Donnell","year":"2005","journal-title":"Anaesthesia"},{"key":"R26-15-20210902","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic interactions with rifampicin: clinical relevance.","volume":"42","author":"Niemi","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"R27-15-20210902","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2165\/00023210-200317070-00004","article-title":"Clinically important drug interactions with zopiclone, zolpidem and zaleplon.","volume":"17","author":"Hesse","year":"2003","journal-title":"CNS Drugs"},{"key":"R28-15-20210902","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2165\/00003088-200544030-00005","article-title":"Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.","volume":"44","author":"Zhou","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R29-15-20210902","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00000542-200404000-00008","article-title":"Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics.","volume":"100","author":"Mertens","year":"2004","journal-title":"Anesthesiology"},{"key":"R30-15-20210902","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00000542-200106000-00006","article-title":"Propofol alters the pharmacokinetics of alfentanil in healthy male volunteers.","volume":"94","author":"Mertens","year":"2001","journal-title":"Anesthesiology"},{"key":"R31-15-20210902","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1097\/00000542-200212000-00005","article-title":"Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil.","volume":"97","author":"Bouillon","year":"2002","journal-title":"Anesthesiology"},{"key":"R32-15-20210902","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/bja\/64.5.563","article-title":"Hepatic and extrahepatic disposition of propofol in patients undergoing coronary-bypass surgery.","volume":"64","author":"Lange","year":"1990","journal-title":"Br J Anaesth"},{"key":"R33-15-20210902","first-page":"1007","article-title":"Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium.","volume":"80","author":"Leslie","year":"1995","journal-title":"Anesth Analg"},{"key":"R34-15-20210902","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3748\/wjg.v9.i9.1959","article-title":"Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes.","volume":"9","author":"Yang","year":"2003","journal-title":"World J Gastroenterol"},{"key":"R36-15-20210902","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0952-8180(97)00237-7","article-title":"Outpatient general anesthesia: a comparison of a combination of midazolam plus propofol and propofol alone.","volume":"9","author":"Reinhart","year":"1997","journal-title":"J Clin Anesth"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0b013e3181da91bb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:16:37Z","timestamp":1786112197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201006000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0b013e3181da91bb","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}